For many years, the American Quarter Horse Association has canvassed provincial/regional/state AQHA Affiliates to submit nominations of qualified AQHA Professional Horsemen/women as the Most Valuable Professional belonging to each international affiliate in recognition of service and support to that affiliate.

According to AQHA, "Only those professionals who have met the qualifications of the AQHA Professional Horsemen and who have agreed to be bound by its code of ethics are eligible for membership."

We learned that Jyssica Heiss recently attended the NSBA World Show laying down personal bests with her recent rides under the guidance of trainer, Melissa Sexton.

Congratulations for heading down to a deep level of competition and rockin' it Jyssica!

The 2018 AQHA Select World Championship Show, presented by Adequan® (polysulfated glycosaminoglycan), kicked off August 24 at the Tri-State Fairgrounds in Amarillo.

Watch the Live Webcast

View the Schedule

Swiss researchers have developed and tested a novel IBH vaccine for horses that minimized the disease-associated inflammation and itching in their trial herd.

If you’ve been itching for an effective insect bite hypersensitivity (IBH) vaccine for your horses, you might soon get some relief. Swiss researchers have developed and tested a novel IBH vaccine for horses that minimized the disease’s effects in their trial herd.

It’s the only IBH vaccine for horses so far to successfully ward off the inflammation and itching caused by biting midges’ saliva in affected horses, said Antonia Fettelschoss-Gabriel, PhD, researcher in the University Hospital Zurich Department of Dermatology, in Schlieren, and at Evax Biotech, in Münchwilen, both in Switzerland.

The new IBH vaccine for horses could appear on the commercial market as early as 2021, if the additional research confirms its efficacy and safety and the transfer to large-scale production is on time, Fettelschoss-Gabriel said.

The study, “Treating insect-bite hypersensitivity in horses with active vaccination against IL-5,” was published in the Journal of Allergy and Clinical Immunology.